Article
Data-derived wearable digital biomarkers predict Frataxin gene expression levels and longitudinal disease progression in Friedreich’s Ataxia
2021-08-16
Abstract excerpt
<title>Abstract</title> <p>Friedreich’s ataxia (FA) is a neurodegenerative disease caused by the epigenetic repression of the <italic>Frataxin</italic> gene modulating mitochondrial activity in the brain, which has a diffuse phenotypic impact on patients’ motor behavior. Therefore, with current gold-standard clinical scales, it requires 18–24 month-long clinical trials to determine if disease-modifying therapies...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4510e0af-c661-5056-af72-5327bafb1871
- DOI
- 10.21203/rs.3.rs-737100/v1
